1.46
Precedente Chiudi:
$1.57
Aprire:
$1.53
Volume 24 ore:
205.12K
Relative Volume:
0.86
Capitalizzazione di mercato:
$6.68M
Reddito:
$895.50K
Utile/perdita netta:
$-26.30M
Rapporto P/E:
-0.0223
EPS:
-65.5728
Flusso di cassa netto:
$-23.84M
1 W Prestazione:
-2.67%
1M Prestazione:
+0.00%
6M Prestazione:
-58.99%
1 anno Prestazione:
-86.48%
Mainz Biomed N V Stock (MYNZ) Company Profile
Nome
Mainz Biomed N V
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MYNZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MYNZ
Mainz Biomed N V
|
1.46 | 8.50M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
558.31 | 210.57B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
214.01 | 153.21B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
627.66 | 50.75B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
143.20 | 41.35B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
217.83 | 37.15B | 15.70B | 1.24B | 2.01B | 6.9036 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | Maxim Group | Buy |
| 2024-11-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Iniziato | H.C. Wainwright | Buy |
Mainz Biomed N V Borsa (MYNZ) Ultime notizie
Building trade automation scripts for Mainz Biomed N.V.2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com
Is Mainz Biomed N.V. stock ready for a breakout2025 Year in Review & Momentum Based Trading Ideas - newser.com
Will Mainz Biomed N.V. stock remain a Wall Street favoriteJuly 2025 Decliners & Capital Efficient Trade Techniques - newser.com
How Mainz Biomed N.V. (4TO) stock performs in easing cyclesJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Will Mainz Biomed N.V. (4TO) stock benefit from mergersJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Will Mainz Biomed N.V. outperform the marketDollar Strength & Growth Focused Investment Plans - newser.com
What dividend safety score for Mainz Biomed N.V. stockFed Meeting & Community Trade Idea Sharing - Fundação Cultural do Pará
Why Mainz Biomed N.V. stock is recommended by analystsMarket Rally & AI Powered Market Entry Strategies - Fundação Cultural do Pará
Will Mainz Biomed N.V. (4TO) stock return to pre crash levelsWeekly Risk Report & Consistent Profit Alerts - newser.com
Can Mainz Biomed N.V. stock continue upward trend2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Will Mainz Biomed N.V. (4TO) stock rise with strong economyMarket Volume Summary & Expert Curated Trade Setups - newser.com
Can Mainz Biomed N.V. stock deliver strong Q4 earnings2025 Macro Impact & Real-Time Volume Analysis - newser.com
Using portfolio simulators with Mainz Biomed N.V. includedTrend Reversal & Stepwise Trade Execution Plans - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Key resistance and support levels for Mainz Biomed N.V.Long Setup & Real-Time Stock Entry Alerts - newser.com
How forex fluctuations impact Mainz Biomed N.V. (4TO) stock2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Is Mainz Biomed N.V. stock affected by interest rate hikesMarket Risk Analysis & Real-Time Price Movement Reports - Fundação Cultural do Pará
Is Mainz Biomed N.V. stock a defensive play in 2025Quarterly Trade Summary & Short-Term High Return Strategies - Fundação Cultural do Pará
What to do if you’re stuck in Mainz Biomed N.V.Profit Target & Daily Technical Stock Forecast Reports - newser.com
Is Mainz Biomed N.V. stock a safe investment in uncertain marketsMarket Movers & Advanced Swing Trade Entry Plans - newser.com
Mainz Biomed N V Azioni (MYNZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):